Teladoc Health to Announce Fourth Quarter 2025 Financial Results
Rhea-AI Summary
Teladoc Health (NYSE: TDOC) will release its fourth quarter 2025 results on Wednesday, February 25, 2026, after market close, and will host a conference call the same day at 5:00 p.m. ET. Investors can access the call by phone, global dial-in, or a live audio webcast.
A replay will be available via webcast shortly after the call and remain online for approximately 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – TDOC
In the Feb 6 session, TDOC gained 5.92%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 12 | Product expansion news | Positive | -2.8% | Launch of enhanced 24/7 Care nationwide expanding virtual urgent care capabilities. |
| Jan 05 | Investor conference | Neutral | +3.3% | CEO presentation at J.P. Morgan Healthcare Conference with webcast access for investors. |
| Nov 26 | Investor conference | Neutral | +1.9% | CEO participation in Piper Sandler Healthcare Conference with webcast replay available. |
| Nov 18 | Partnership news | Positive | +3.7% | Integration of TytoCare home diagnostics with Teladoc primary and urgent care programs. |
| Nov 06 | Equity compensation | Neutral | -1.2% | Employee inducement award of RSUs and PSUs for new Chief Technology Officer. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news often saw muted or negative next-day moves, even on operationally positive updates.
Over the last few months, Teladoc Health issued several operational and corporate updates. A Nov 6, 2025 inducement award announcement (RSUs/PSUs) and the Nov 18, 2025 TytoCare integration news were followed by modest price reactions. Subsequent investor conference participations on Nov 26, 2025 and Jan 5, 2026 produced small positive moves. However, the enhanced 24/7 Care launch on Jan 12, 2026 coincided with a negative reaction. Today’s earnings-date notice fits this pattern of informational releases around strategic initiatives and investor-facing events.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
Conference Call Details
The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 330912. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=95347. A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/.
A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.
Investors:
Michael Minchak
IR@teladochealth.com
617-444-9612
